Skip to main content
ZyVersa Therapeutics, Inc. (ZVSA)
NASDAQ: ZVSA · IEX Real-Time Price · USD
0.575
-0.016 (-2.74%)
At close: Apr 22, 2024, 4:00 PM
0.586
+0.011 (1.95%)
Pre-market: Apr 23, 2024, 8:06 AM EDT

ZyVersa Therapeutics Market Cap

ZyVersa Therapeutics has a market cap or net worth of $4.37 million as of April 23, 2024. Its market cap has decreased by -73.22% in one year.

Market Cap
4.37M
Enterprise Value
1.24M
1-Year Change
-73.22%
Ranking
#5462
Category
Nano-Cap
Stock Price
$0.57

Market Cap Chart

Since December 21, 2021, ZyVersa Therapeutics's market cap has decreased from $96.70M to $4.37M, a decrease of -95.49%. That is a compound annual growth rate of -73.56%.

History

DateMarket Cap% Change
Apr 19, 20244.50M-6.25%
Apr 18, 20244.80M9.09%
Apr 17, 20244.40M-
Apr 16, 20244.40M-8.33%
Apr 15, 20244.80M-11.11%
Apr 12, 20245.40M-5.26%
Apr 11, 20245.70M-
Apr 10, 20245.70M3.64%
Apr 9, 20245.50M-1.79%
Apr 8, 20245.60M-
Apr 5, 20245.60M-
Apr 4, 20245.60M3.70%
Apr 3, 20245.40M-1.82%
Apr 2, 20245.50M-3.51%
Apr 1, 20245.70M-
Mar 28, 20245.70M-3.39%
Mar 27, 20245.90M3.51%
Mar 26, 20245.70M-6.56%
Mar 25, 20246.10M56.41%
Mar 22, 20243.90M-
Mar 21, 20243.90M-2.50%
Mar 20, 20244.00M2.56%
Mar 19, 20243.90M-4.88%
Mar 18, 20244.10M7.89%
Mar 15, 20243.80M-
View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
BIOLASE 4.52M
Processa Pharmaceuticals 4.51M
Lipella Pharmaceuticals 4.49M
Sharps Technology 4.48M
Xylo Technologies 4.47M
Tharimmune 4.43M
Virpax Pharmaceuticals 4.31M
Artelo Biosciences 4.24M
Market Cap Rankings